drugset / Trial / NCT04194216

Summary

This study compares the efficacy of a single intra-operative (intravenous) dose of "cephalexin" (first generation cephalosporin) or "clindamycin" (lincosamides), alone versus both intra-operative (intravenous) dose of "cephalexin" (first generation cephalosporin) or "clindamycin" (lincosamides) and postoperative oral dose of "cephalexin" or "clindamycin" use in nasal surgery.

Timeline

Start
2020-05-20
Primary completion
2026-12-20
Completion
2027-04-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator CEPHALEXIN ANHYDROUS Small molecule 250 mg Intravenous
Comparator CEPHALEXIN ANHYDROUS Small molecule 2 g Intravenous
Comparator Clindamycin Unknown 150 mg Intravenous
Comparator Clindamycin Unknown 900 mg Intravenous

Indications